AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 4723266 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 12
Study 30484117 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (400 U injected into the affected upper limb)
Number of subjects: 296
Study 29224827 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification using the Fisher & Paykel Healthcare MR880 humidifier
Number of subjects: 39
Study 29224827 — intervention group
Group type: COMPARATOR
Intervention: Control group (no humidification)
Number of subjects: 39
Study 29224827 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification
Number of subjects: 39
Study 26823235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 12 h intervals
Number of subjects: 39
Study 26823235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 24 h intervals
Number of subjects: 39
Study 26823235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 48 h intervals
Number of subjects: 39
Study 24568224 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 30
Study 24568224 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated training
Number of subjects: 30
Study 24568224 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 23037875 — intervention group
Group type: EXPERIMENTAL
Intervention: Late administration of surfactant (up to 5 doses) plus prolonged inhaled nitric oxide (iNO)
Number of subjects: 85
Study 23037875 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nitric oxide (iNO) alone
Number of subjects: 85
Study 20335831 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 0.75 mg BID
Number of subjects: 100
Study 20335831 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg BID
Number of subjects: 100
Study 17621415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (200 mg/day, 100 mg twice a day; n = 16 patients)
Number of subjects: 40
Study 17621415 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 24 patients)
Number of subjects: 40
Study 17621415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac group
Number of subjects: 40
Study 15665025 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (AH)
Number of subjects: 160
Study 15665025 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser-assisted hatching)
Number of subjects: 160
Study 11990441 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix protein derivative (EMD) combined with bioactive glass (BG)
Number of subjects: 28
Study 11990441 — intervention group
Group type: COMPARATOR
Intervention: Bioactive glass (BG) alone
Number of subjects: 28
Study 9440402 — intervention group
Group type: EXPERIMENTAL
Intervention: Preliminary notification
Number of subjects: 2000
Study 9440402 — intervention group
Group type: EXPERIMENTAL
Intervention: Short length of the questionnaire
Number of subjects: 2000
Study 9440402 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of preliminary notification, short questionnaire, and no mention of telephone contact
Number of subjects: 2000
Study 9440402 — intervention group
Group type: COMPARATOR
Intervention: Combination of no preliminary notification, long questionnaire, and mention of telephone contact
Number of subjects: 2000
Study 9440402 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics (young age, male sex, urban residence)
Number of subjects: 2000
Study 9440402 — intervention group
Group type: EXPERIMENTAL
Intervention: Old age
Number of subjects: 2000
Study 10781270 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic state
Number of subjects: 11
Study 10781270 — intervention group
Group type: COMPARATOR
Intervention: Resting state
Number of subjects: 11
Study 10781270 — intervention group
Group type: COMPARATOR
Intervention: Mental imagery
Number of subjects: 11
Study 1991261 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus fluoxymesterone (TAM + FLU)
Number of subjects: 238
Study 1991261 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (TAM) alone
Number of subjects: 238
Study 1991261 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus fluoxymesterone (TAM + FLU) in patients aged 65 or older with ER of 10 or greater
Number of subjects: 238
Study 6185212 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP-BCG
Number of subjects: 652
Study 6185212 — intervention group
Group type: COMPARATOR
Intervention: CHOP-bleomycin
Number of subjects: 652
Study 6185212 — intervention group
Group type: COMPARATOR
Intervention: COP-bleomycin
Number of subjects: 652
Study 31564241 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced oral healthcare
Number of subjects: 325
Study 31564241 — intervention group
Group type: COMPARATOR
Intervention: Usual oral healthcare
Number of subjects: 325
Study 30584118 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervical and upper thoracic spine mobilization
Number of subjects: 31
Study 30584118 — intervention group
Group type: COMPARATOR
Intervention: Deep cervical flexors exercise (DCFE)
Number of subjects: 31
Study 27613901 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth reinforcement
Number of subjects: 90
Study 27613901 — intervention group
Group type: COMPARATOR
Intervention: mHealth monitoring
Number of subjects: 90
Study 27290982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D; n=25)
Number of subjects: 50
Study 27290982 — intervention group
Group type: COMPARATOR
Intervention: Propofol (group P; n=25)
Number of subjects: 50
Study 27290982 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 27359067 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU daily) for 2 months prior to surgery
Number of subjects: 27
Study 27359067 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 months prior to surgery
Number of subjects: 27
Study 23895860 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.3 µg/kg loading dose, 0.3 µg·kg(‐1)·h(‐1) maintenance dose)
Number of subjects: 22
Study 23895860 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 22
Study 22180397 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense weekly paclitaxel 80 mg/m(2) plus 3-weekly carboplatin AUC 6
Number of subjects: 0
Study 22180397 — intervention group
Group type: COMPARATOR
Intervention: 3-weekly paclitaxel/carboplatin
Number of subjects: 0
Study 19210629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 315
Study 19210629 — intervention group
Group type: COMPARATOR
Intervention: Drug
Number of subjects: 315
Study 17116705 — intervention group
Group type: EXPERIMENTAL
Intervention: Chili (4.2 g dry powder, 25 mg polyphenols as gallic acid equivalents)
Number of subjects: 10
Study 17116705 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric (0.5 g dry powder, 50 mg polyphenols as gallic acid equivalents)
Number of subjects: 10
Study 17116705 — intervention group
Group type: EXPERIMENTAL
Intervention: Chili (4.2 g dry powder)
Number of subjects: 10
Study 14742340 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% solution (0.7 ml x kg(‐1))
Number of subjects: 6
Study 14742340 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% solution (0.7 ml x kg(‐1))
Number of subjects: 6
Study 14742340 — intervention group
Group type: COMPARATOR
Intervention: Fascia iliaca compartment block
Number of subjects: 6
Study 11728893 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education program (West African Youth Initiative)
Number of subjects: 0
Study 11728893 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10795779 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 28
Study 10795779 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport drink A (carbohydrate and electrolytes)
Number of subjects: 28
Study 10795779 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport drink B (carbohydrate, fat, and protein)
Number of subjects: 28
Study 10795779 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 28
Study 10795779 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 28
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (40 mg and higher)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (80 mg)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (120 mg and 160 mg)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (100 mg-140 mg)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (100 mg upwards)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014 (40, 60, 80, 100, and 140 mg)
Number of subjects: 8
Study 10188789 — intervention group
Group type: EXPERIMENTAL
Intervention: WAL 2014
Number of subjects: 8
Study 10188789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2165800 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium iso‐nonanoyl oxybenzene sulphonate (SINOS) 0.01‐100 micrograms
Number of subjects: 9
Study 2165800 — intervention group
Group type: COMPARATOR
Intervention: Linear alkyl benzene sulphonate (LAS) 0.01‐100 micrograms
Number of subjects: 9
Study 2165800 — intervention group
Group type: COMPARATOR
Intervention: Sodium iso‐nonanoyl oxybenzene sulphonate (SINOS)
Number of subjects: 9
Study 653534 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine administration in normal postpartum women
Number of subjects: 2
Study 653534 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine administration in patients with chlorpromazine-induced hyperprolactinaemia
Number of subjects: 2
Study 653534 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal postpartum women)
Number of subjects: 2
Study 653534 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with chlorpromazine-induced hyperprolactinaemia)
Number of subjects: 2
Study 31055009 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling enjoyment (mention of carrot sticks that characters like)
Number of subjects: 155
Study 31055009 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling intake (mention of carrot sticks that all characters ate)
Number of subjects: 155
Study 31055009 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling enjoyment
Number of subjects: 155
Study 31055009 — intervention group
Group type: COMPARATOR
Intervention: Control (no mention of carrot sticks)
Number of subjects: 155
Study 29186759 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU of vitamin D
Number of subjects: 90
Study 26159452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweeting arm (intervention group) - three tweets daily using Hootsuite with specific content related to the systematic reviews.
Number of subjects: 170
Study 26159452 — intervention group
Group type: COMPARATOR
Intervention: Non-tweeting arm (control group) - no tweets.
Number of subjects: 170
Study 26159452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweeting arm (intervention group)
Number of subjects: 170
Study 26159452 — intervention group
Group type: COMPARATOR
Intervention: Non-tweeting arm (control group)
Number of subjects: 170
Study 23864583 — intervention group
Group type: EXPERIMENTAL
Intervention: Race-conscious blacks
Number of subjects: 100
Study 23864583 — intervention group
Group type: EXPERIMENTAL
Intervention: Race-conscious whites
Number of subjects: 100
Study 23864583 — intervention group
Group type: COMPARATOR
Intervention: Non-race-conscious blacks
Number of subjects: 100
Study 23864583 — intervention group
Group type: COMPARATOR
Intervention: Non-race-conscious whites
Number of subjects: 100
Study 22001341 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration-assisted anesthesia during BTX‐A injections
Number of subjects: 50
Study 22001341 — intervention group
Group type: COMPARATOR
Intervention: BTX‐A injections alone (control)
Number of subjects: 50
Study 22001341 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration-assisted anesthesia
Number of subjects: 50
Study 19441605 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine-montelukast (10 mg/10 mg)
Number of subjects: 0
Study 19441605 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 19441605 — intervention group
Group type: COMPARATOR
Intervention: phenylephrine (10 mg)
Number of subjects: 0
Study 16620740 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced drivers
Number of subjects: 2
Study 16620740 — intervention group
Group type: COMPARATOR
Intervention: Inexperienced drivers
Number of subjects: 2
Study 15262244 — intervention group
Group type: EXPERIMENTAL
Intervention: NASHA
Number of subjects: 346
Study 15262244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study 11515928 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 0
Study 11515928 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 11515928 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study 8993254 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 20 mg/kg body weight (S group)
Number of subjects: 24
Study 8993254 — intervention group
Group type: COMPARATOR
Intervention: Placebo (C group)
Number of subjects: 24
Study 8993254 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (S group)
Number of subjects: 24
Study 10419708 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with 5-FUDR (Protocol A)
Number of subjects: 168
Study 10419708 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with 5-FUDR + i.v. (Protocol B)
Number of subjects: 168
Study 10419708 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with 5-FU + FA (Protocol C)
Number of subjects: 168
Study 10419708 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with MFFM (Protocol D)
Number of subjects: 168
Study 10419708 — intervention group
Group type: COMPARATOR
Intervention: HAI with 5-FUDR or 5-FU + FA (Control)
Number of subjects: 168
Study 2115819 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 129
Study 2115819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 414557 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodoxamate
Number of subjects: 0
Study 414557 — intervention group
Group type: COMPARATOR
Intervention: Iodipamide
Number of subjects: 0
Study 30859204 — intervention group
Group type: EXPERIMENTAL
Intervention: 18S rDNA copy number quartiles
Number of subjects: 229
Study 30859204 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.8S rDNA copy number quartiles
Number of subjects: 229
Study 28688667 — intervention group
Group type: COMPARATOR
Intervention: ICG alone
Number of subjects: 127
Study 28688667 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG and blue dye
Number of subjects: 127
Study 25375979 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐α (12 ng/kg/h) infusion
Number of subjects: 16
Study 23971620 — intervention group
Group type: EXPERIMENTAL
Intervention: ω3 PUFA (n=7)
Number of subjects: 16
Study 23971620 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=9)
Number of subjects: 16
Study 23971620 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ω3 PUFA and Placebo
Number of subjects: 16
Study 22256576 — intervention group
Group type: EXPERIMENTAL
Intervention: FA plus TH (Flurbiprofen axetil 4 mg kg‐1 . 24 hr‐1 and Tramadol hydrochloride 2 mg kg‐1 . 24 hr‐1 after bolus injection of FA 50 mg)
Number of subjects: 50
Study 22256576 — intervention group
Group type: EXPERIMENTAL
Intervention: FA alone (Flurbiprofen axetil 4 mg kg‐1 . 24 hr‐1)
Number of subjects: 50
Study 22256576 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 50
Study 19565736 — intervention group
Group type: EXPERIMENTAL
Intervention: Pricking blood therapy combined with ultraviolet irradiation
Number of subjects: 130
Study 19565736 — intervention group
Group type: COMPARATOR
Intervention: Aciclovir and other western medicine
Number of subjects: 130
Study 16455427 — intervention group
Group type: EXPERIMENTAL
Intervention: Early group (within 5 days after embolism)
Number of subjects: 39
Study 16455427 — intervention group
Group type: COMPARATOR
Intervention: Late group (more than 5 days after embolism)
Number of subjects: 39
Study 15236807 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual withdrawal treatment approaches
Number of subjects: 76
Study 11238433 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass media health education campaign for TB control
Number of subjects: 0
Study 8981389 — intervention group
Group type: EXPERIMENTAL
Intervention: mCPP (0.1 mg/kg)
Number of subjects: 26
Study 8981389 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg)
Number of subjects: 26
Study 8981389 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 26
Study 8513291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg starting dose, followed by 100 mg weekly)
Number of subjects: 13
Study 8513291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2878867 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg p.o.)
Number of subjects: 8
Study 2878867 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg p.o.)
Number of subjects: 8
Study 2878867 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (5 mg sublingually)
Number of subjects: 8
Study 31233269 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive framing
Number of subjects: 96
Study 31233269 — intervention group
Group type: COMPARATOR
Intervention: Negative framing
Number of subjects: 96
Study 30053278 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg 25(OH)D3 daily
Number of subjects: 78
Study 30053278 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg vitamin D3 daily
Number of subjects: 78
Study 30053278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 26341679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoalveolar molding (NAM) performed by 1 month of age (group I, n = 50)
Number of subjects: 150
Study 26341679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoalveolar molding (NAM) performed at 1 to 6 months of age (group II, n = 50)
Number of subjects: 150
Study 26341679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoalveolar molding (NAM) performed at 6 months to 1 year of age (group III, n = 50)
Number of subjects: 150
Study 25093275 — intervention group
Group type: EXPERIMENTAL
Intervention: 135 g serving of lean beef (tinned meat) providing 20 g of protein and 1.7 g of fat after resistance training.
Number of subjects: 26
Study 25093275 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation).
Number of subjects: 26
Study 22167633 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual education by videotape (video group)
Number of subjects: 133
Study 22167633 — intervention group
Group type: COMPARATOR
Intervention: Control group (only information given)
Number of subjects: 133
Study 22167633 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent patients using CPAP effectively
Number of subjects: 133
Study 22167633 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of CPAP use
Number of subjects: 133
Study 22167633 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects (mask intolerance, choking, noise, nasal congestion)
Number of subjects: 133
Study 21111314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet-A/riboflavin CXL therapy
Number of subjects: 0
Study 21111314 — intervention group
Group type: COMPARATOR
Intervention: Riboflavin alone without epithelial debridement (Control)
Number of subjects: 0
Study 18515652 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT) for 3 months
Number of subjects: 19
Study 18515652 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal stretch fraction (ISF)
Number of subjects: 19
Study 18515652 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal stretch fraction (ISF) > 0.4
Number of subjects: 19
Study 15837100 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of T. arjuna
Number of subjects: 40
Study 15837100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12888363 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (48‐54 Gy)
Number of subjects: 1187
Study 12888363 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 1187
Study 10533698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear mixed‐effects model (Emax) with interindividual and interoccasion variability (IOV)
Number of subjects: 37
Study 10533698 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear mixed‐effects model
Number of subjects: 37
Study 10533698 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations based on a similar study design
Number of subjects: 37
Study 10533698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear mixed‐effects model
Number of subjects: 37
Study 8691512 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Blood Autotransfusion (WBA)
Number of subjects: 32
Study 8691512 — intervention group
Group type: COMPARATOR
Intervention: Cell Separation (CS)
Number of subjects: 32
Study 1881729 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Home Care (PHC) program
Number of subjects: 219
Study 1881729 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 219
Study 7049708 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticrynafen
Number of subjects: 11
Study 7049708 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 11
Study 31830078 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led interpersonal communication (IPC) intervention
Number of subjects: 2430
Study 31830078 — intervention group
Group type: COMPARATOR
Intervention: Control (mass media campaign only)
Number of subjects: 2430